<DOC>
	<DOCNO>NCT00834873</DOCNO>
	<brief_summary>The objective randomized , single-dose , two-way crossover evaluation compare relative bioequivalence test carvedilol formulation ( TEVA Pharmaceuticals USA ) equivalent oral dose commercially available carvedilol ( COREGÂ® , SmithKline Beecham Pharmaceuticals ) test population 24 adult individual feed condition .</brief_summary>
	<brief_title>Carvedilol ( 25 mg ) 24 Fed , Healthy , Adult Subjects</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Sex : Male Female ; similar proportion prefer . Age : At least 18 year . Weight : Minimum 120 pound BMI ( body mass index ) less 30 . Subjects comply inclusion criterion must exclude study . In addition , one condition list exclude subject study . History treatment alcoholism , substance abuse , drug abuse within past 24 month History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . History treatment gastrointestinal disorder within past five ( 5 ) year . History , presence , asthma History peripheral vascular disease History heart failure History preexisting cardiac arrythmias associate tachycardia History severe sensitivity allergen , require urgent medical treatment . Females pregnant lactate History hypersensitivity carvedilol , beta adrenergic block drug . Conditions upon screen might contraindicate require caution use administration carvedilol , include : sit systolic blood pressure 100 mmHg , diastolic pressure 60 mmHg . Heart rate le 60 beat per minute 5minute rest seat position . Inability read and/or sign consent form . Treatment investigational drug four ( 4 ) week prior initial dose study . Subjects smoke use tobacco product currently use nicotine product ( patch , gum , etc . ) Ninety ( 90 ) day abstinence require . subject donate blood within four ( 4 ) week prior initial dose study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>